Pretreatment anxious depression as a predictor of side effect frequency and severity in escitalopram and aripiprazole adjunctive therapy-Reference-Cited by-同舟云学术

Pretreatment anxious depression as a predictor of side effect frequency and severity in escitalopram and aripiprazole adjunctive therapy

Published:2022-03-25 Issue:5 Volume:12 Page:
ISSN:2162-3279
Container-title:Brain and Behavior
language:en
Short-container-title:Brain and Behavior

Author:

Espinola Caroline W.¹²^ORCID,Khoo Yuelee¹,Parmar Roohie¹,Demchenko Ilya¹,Frey Benicio N.³⁴^ORCID,Milev Roumen V.⁵,Ravindran Arun V.²⁶,Parikh Sagar V.⁷,Ho Keith¹,Rotzinger Susan¹,Lou Wendy⁸,Lam Raymond W.⁹,Kennedy Sidney H.¹²⁶¹⁰,Bhat Venkat¹²⁶¹⁰,

Affiliation:

1. Interventional Psychiatry Program St. Michael's Hospital Toronto Ontario Canada

2. Department of Psychiatry University of Toronto Toronto Ontario Canada

3. Department of Psychiatry and Behavioural Neurosciences McMaster University Hamilton Ontario Canada

4. Mood Disorders Program and Women's Health Concerns Clinic St. Joseph's Healthcare Hamilton Ontario Canada

5. Departments of Psychiatry and Psychology Queen's University Providence Care Kingston Ontario Canada

6. Institute of Medical Science University of Toronto Toronto Ontario Canada

7. Department of Psychiatry University of Michigan Ann Arbor Michigan USA

8. Division of Biostatistics, Dalla Lana School of Public Health University of Toronto Toronto Ontario Canada

9. Department of Psychiatry University of British Columbia Vancouver British Columbia Canada

10. Li Ka Shing Knowledge Institute St. Michael's Hospital & Krembil Research Institute University Health Network Toronto Ontario Canada

Publisher

Wiley

Subject

Behavioral Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/brb3.2555

Reference50 articles.

1. Rates of 5 Common Antidepressant Side Effects Among New Adult and Adolescent Cases of Depression: A Retrospective US Claims Study

2. Escitalopram Therapy for Major Depression and Anxiety Disorders

3. Escitalopram Therapy for Major Depression and Anxiety Disorders

4. Escitalopram in the treatment of anxiety symptoms associated with depression

5. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical correlates of anxious depression in youth from the Texas Youth Depression and Suicide Research Network (TX-YDSRN);Journal of Affective Disorders;2024-10

2. Measuring the Influence of Side Effect Expectations, Beliefs, and Incident Side Effects on the Risk for Drug Discontinuation Among Individuals Starting New Medications, a Cross-sectional Study;Patient Preference and Adherence;2024-05

3. Unveiling potential adverse events associated with escitalopram oxalate: A real-world analysis based FDA adverse event reporting system database;Journal of Psychopharmacology;2024-04-27

4. Measuring the influence of expectations, beliefs, and medication side effects on the risk for drug discontinuation among individuals starting new medications;2023-09-19

5. Effects of Exercise Intervention on Students’ Test Anxiety: A Systematic Review with a Meta-Analysis;International Journal of Environmental Research and Public Health;2022-05-31